Intracerebral haemorrhage associated with sildenafil citrate
Intracerebral haemorrhage associated with sildenafil citrate
复制标题
与枸橼酸西地那非相关的脑出血
DOI:
10.1007/s004150170250
复制
发表时间:
2001
影响因子:
6
通讯作者:
R. Camarda
中科院分区:
文献类型:
--
作者:
R. Monastero;C. Pipia;L. Camarda;R. Camarda
Sirs: Sildenafil is an orally active, potent and selective inhibitor of phosphodiesterase type 5 (PDE–5), an important regulator of cyclic guanosine monophosphate (cGMP) in the human corpus cavernosum which has recently been introduced for the treatment of erectile dysfunction. Sildenafil acts by increasing the concentration of cGMP in the corpus cavernosum smooth muscle cells leading to muscle relaxation, vasodilatation and penile erection [1]. Adverse effects include headache, visual and retinal disturbances, dizziness and a pupil-sparing third nerve palsy [2, 5, 7]. We report a patient who developed intracerebral haemorrhage (ICH) after sildenafil consumption. A 67-year-old dentist was referred to our clinic in a confusional state together with speech, numeracy and memory disturbances. From the history it appeared that 5 days before admission, approximately 30 minutes after the ingestion of one tablet of sildenafil 25 mg, the patient complained of headache, confusion and nervousness without improvement in sexual function. One hour after the ingestion of the first tablet the patient took another 25 mg tablet, again without sexual intercourse. According to his wife, these symptoms increased together with language difficulty. The patient was admitted to our department 5 days later. He had never used sildenafil before. The history revealed no arterial hypertension or migraine or haemostatic risk factors (e. g. use of anticoagulants or antiplatelet drugs, thrombolytic treatment), history of head trauma, hypercholesterolaemia, diabetes mellitus, pre-existing cardiovascular disease or cerebrovascular episodes such as stroke or transient ischaemic attacks. There was no family history of cerebral arteriovenous malformation, intracerebral aneurysms, or intracerebral haemorrhages. He had a 40-year history of tobacco abuse (approximately 15 cigarettes a day) and denied regular alcohol intake. He took no other medications. On admission his blood pressure was 140/90 mmHg and pulse was 68/min. Neurological examination showed a right superior homonymous quadrantopsia and psychiatric examination a dysphoretic mood. Ophthalmoscopic examination was normal. Neuropsychological testing revealed a moderate impairment of comprehension, naming, reading and writing with a relative sparing of repetition, acalculia, finger agnosia, colour anomia, and discrete involvement of episodic memory. Routine blood examination, platelet count and coagulation factors were normal, as well as electrocardiography, and colour-coded duplex sonography of extracranial vessels. Transcranial colour-coded duplex sonography revealed a sharply demarcated hyperechogenic area confined to the left temporal lobe. Two days after admission basal and gadolinium-enhanced T1-/T2-weighted cerebral magnetic resonance imaging revealed a large left temporal subcortical haemorrhage with moderate surrounding oedema (see Fig. 1). Although the chance of finding a clinically relevant vascular lesion in a patient 67 years old is very small, we would have liked to have performed cerebral angiography. However, the patient’s wife, informed of the potential risk of cerebral angiography, refused her consent due to her husband’s advanced age and the presence of a deep lobar ICH. The patient was treated with intravenous bolus of 1 g/kg mannitol, followed by 0.5 g/kg every 4 h for 7 days. He was discharged 5 days later with mild comprehension, reading, writing and episodic memory deficits, moderate acalculia, finger agnosia and colour anomia. The field defect was still present. The close temporal relationship between sildenafil ingestion and onset of the neurological symptoms due to the ICH in a patient without a history of cerebrovascular accident or obvious risk factors for ICH suggest that sildenafil was causally related to the ICH. Smoking is currently not considered a primary risk factor for ICH [4, 6]. Since the symptoms started before any attempt at sexual intercourse, sexual exertion cannot be regarded LETTER TO THE EDITORS